Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000075048 | SCV000106047 | pathogenic | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Large deletion |
Invitae | RCV000468214 | SCV000563814 | pathogenic | Lynch syndrome | 2016-11-28 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing the promoter and exons 1-13 of the MLH1 gene, which includes the initiator codon. It is expected to disrupt mRNA transcription and abrogate the initiation of protein translation of MLH1. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 13 of the MLH1 gene. Exon-level deletions and loss-of-function variants in MLH1 are known to be pathogenic. Deletions encompassing exons 1-13 have been observed in individuals affected with Lynch syndrome (PMID: 12658575, 16143124). For these reasons, this variant has been classified as Pathogenic. |